What can our genetic background reveal? Unlocking new possibilities for neuromuscular disorder care through CoMPaSS-NMD approach. Our genetic background acts as an "instruction manual" for how we develop, function, and express various traits, including susceptibility to diseases, physical features, and even behaviors. For patients with neuromuscular disorders, this genetic diversity plays a crucial role [...]
Your health, our CoMPaSS: Welcome to the CoMPaSS-NMD Newsletter! We are thrilled to launch the first issue of our project newsletter, keeping you informed about the exciting progress of CoMPaSS-NMD (Computational Models for new Patients Stratification Strategies of Neuromuscular Disorders). In this issue: 1. A project overview Our objectives: Faster and more accurate diagnoses [...]
What do the 2024 Nobel Prizes in Physics and Chemistry have in common with the CoMPaSS-NMD Project? Two words: Artificial Intelligence (AI). "For fundamental discoveries and inventions that have made machine learning possible with artificial neural networks". This is the official recognition given to the 2024 Nobel Prize in Physics, jointly awarded to John [...]
The CoMPaSS-NMD project is at the forefront of developing innovative computational approaches to revolutionize patient stratification in neuromuscular disorders (NMDs). To support this mission, the Young Investigator Training (YIT) initiative was established to foster the growth of young researchers in the field. The YIT Initiative: the 2024 summer editionย The YIT 1 program, from [...]
CoMPaSS-NMD launchs its first NMD awareness webinar titled Unmet Needs in Muscle Disorders: Can AI Provide the Solution? Join us for a groundbreaking webinar to explore the potential of artificial intelligence (AI) in revolutionizing the diagnosis and treatment of neuromuscular disorders (NMDs). Leading experts in neurology, molecular genetics, and AI will discuss the critical [...]
Are you a young researcher interested in Neuromuscular Disorders (NMDs)? The CoMPaSS-NMD project is excited to announce the ๐ฌ๐ผ๐๐ป๐ด ๐๐ป๐๐ฒ๐๐๐ถ๐ด๐ฎ๐๐ผ๐ฟ ๐ง๐ฟ๐ฎ๐ถ๐ป๐ถ๐ป๐ด (๐ฌ๐๐ง) initiative! This EU-funded program aims to train a new generation of researchers in NMDs and equip them with the latest techniques for diagnosis and trial preparation. ๐ช๐ต๐ฎ๐ ๐ถ๐ ๐๐ต๐ฒ ๐ฌ๐๐ง ๐ถ๐ป๐ถ๐๐ถ๐ฎ๐๐ถ๐๐ฒ? The [...]
Modena, Italy - June 21, 2024 - The CoMPaSS-NMD clinic is a new specialized center for neuromuscular diseases. Patients can now benefit from expert doctors and innovative diagnostic technologies (based on artificial intelligence) that can improve the lives of people with neuromuscular diseases and their caregivers. Thanks to artificial intelligence, doctors will be able [...]
Our coordinator, Rossella Tupler, fromย Universitร degli Studi di Modena e Reggio Emilia, will present theย CoMPaSS-NMDย project at the 7th Italian Neuromuscular Disease Day. When? Next Saturday, 13 April. Where? In Parma, Italy...and other 18 italian cities!! The aim of the event is to provide an update on the state of the art at national, regional [...]
Hereditary Neuromuscular Diseases are rare multifactorial conditions difficult to ascertain; it's noteworthy that ๐ฒ๐ฌ% of patients lack an accurate diagnosis. In Europe, ๐ฑ๐ฌ๐ฌ ๐๐ต๐ผ๐๐๐ฎ๐ป๐ฑ people suffer from these diseases, with ๐ฏ๐ฌ% of cases leading to permanent disability. CoMPaSS-NMD proposes an innovative approach to diagnose these diseases based on Artificial Intelligence. "The goal is to [...]
The CoMPaSS-NMD consortium met in person for the second time after the kick-off meeting in June 2023, hosted by Ludwig-Maximilians-Universitรคt Mรผnchen, in a beautiful historic location, the Carl Friedrich von Siemens Foundation, established in 1958 on the initiative of entrepreneurย Ernst von Siemens. It bears the name of his father Carl Friedrich von Siemens, who [...]